Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage
- PMID: 9082945
- DOI: 10.1002/art.1780400323
Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage
Abstract
Objective: To evaluate the anabolic activity of osteoarthritic chondrocytes in situ by investigating the messenger RNA (mRNA) expression of 3 major cartilage components, type II collagen, aggrecan, and link protein:
Methods: In situ hybridization experiments and histochemical analysis for proteoglycan content were performed on parallel sections of normal and osteoarthritic (OA) cartilage specimens.
Results: Most chondrocytes in the deeper.zones of OA cartilage showed an increase in mRNA expression, in particular, of type II collagen and to a lesser extent, aggrecan, compared with normal specimens. However, chondrocytes of the upper zone were largely negative for aggrecan or type II collagen mRNA. The expression of link protein mRNA was low in normal and OA specimens.
Conclusion: These observations suggest that suppression of the anabolic activity of chondrocytes in the upper zones contributes to the metabolic imbalance observed in OA cartilage. Stimulation of matrix anabolism in superficial chondrocytes might be a suitable target for therapeutic intervention.
Similar articles
-
Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes.Arthritis Rheum. 2000 Sep;43(9):2091-9. doi: 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C. Arthritis Rheum. 2000. PMID: 11014361
-
Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples.Arthritis Rheum. 1997 Jun;40(6):1037-45. doi: 10.1002/art.1780400607. Arthritis Rheum. 1997. PMID: 9182913
-
Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis.Arthritis Rheum. 1995 Mar;38(3):420-5. doi: 10.1002/art.1780380320. Arthritis Rheum. 1995. PMID: 7533495
-
Cartilage proteoglycans.Semin Cell Dev Biol. 2001 Apr;12(2):69-78. doi: 10.1006/scdb.2000.0243. Semin Cell Dev Biol. 2001. PMID: 11292372 Review.
-
[Structure and regulation of articular cartilage proteoglycan expression].Pathol Biol (Paris). 2001 May;49(4):364-75. doi: 10.1016/s0369-8114(01)00145-6. Pathol Biol (Paris). 2001. PMID: 11428173 Review. French.
Cited by
-
Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions.J Nanobiotechnology. 2021 Mar 25;19(1):83. doi: 10.1186/s12951-021-00830-7. J Nanobiotechnology. 2021. PMID: 33766057 Free PMC article.
-
Applications of proteomics to osteoarthritis, a musculoskeletal disease characterized by aging.Front Physiol. 2011 Dec 23;2:108. doi: 10.3389/fphys.2011.00108. eCollection 2011. Front Physiol. 2011. PMID: 22207853 Free PMC article.
-
Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism.Ann Rheum Dis. 2008 Dec;67 Suppl 3(0 3):iii75-82. doi: 10.1136/ard.2008.098764. Ann Rheum Dis. 2008. PMID: 19022820 Free PMC article. Review.
-
Definition of a Critical Size Osteochondral Knee Defect and its Negative Effect on the Surrounding Articular Cartilage in the Rat.Osteoarthritis Cartilage. 2017 Sep;25(9):1531-1540. doi: 10.1016/j.joca.2017.05.006. Epub 2017 May 12. Osteoarthritis Cartilage. 2017. PMID: 28506841 Free PMC article.
-
Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes.Arthritis Rheum. 2008 Jul;58(7):2075-87. doi: 10.1002/art.23504. Arthritis Rheum. 2008. PMID: 18576389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
